Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics

World Journal of Gastroenterology

Volumn 11, Issue 43, 2005, Pages 6823-6827

  Chen, Tian An ^a   Lo, Gin Ho ^a   Lai, Kwok Hung ^a   Lin, Whey Jen ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Amikacin; Cefotaxime; Spontaneous bacterial peritonitis

Indexed keywords

AMIKACIN; BETA 2 MICROGLOBULIN; CEFOTAXIME;

ADULT; AGED; ARTICLE; BACTERIAL PERITONITIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; KIDNEY DYSFUNCTION; LIVER CIRRHOSIS; MALE; NEPHROTOXICITY; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SINGLE DRUG DOSE; TREATMENT OUTCOME;

EID: 30744447235     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i43.6823     Document Type: Article

References (21)

1. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001; 120: 726-748
2. Mowat C, Stanley AJ. Review article: spontaneous bacterial peritonitis - diagnosis, treatment and prevention. Aliment Pharmacol Ther 2001; 15: 1851-1859
3. Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, Rimola A, Gassull MA, Arroyo V, Rodes J. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994; 20: 1495-1501
4. Cabrera J, Arroyo V, Ballesta AM, Rimola A, Gual J, Elena M, Rodes J. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage. Gastroenterology 1982; 82: 97-105
5. McCormick PA, Greenslade L, Kibbler CC, Chin JK, Burroughs AK, McIntyre N. A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients. Hepatology 1997; 25: 833-836
6. Prins JM, Buller HR, Kuijper EJ, Tange RA, Speelman P. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993; 341: 335-339
7. Kumana CR, Yuen KY. Parenteral aminoglycoside therapy. Selection, administration and monitoring. Drugs 1994; 47: 902-913
8. Mauracher EH, Lau WY, Kartowisastro H, Ong KH, Genato VX, Limson B, Yusi GM, Liu CY, Suwangool P. Comparison of once-daily and thrice-daily netilmicin regimens in serious systemic infections: a multicenter study in six Asian countries. Clin Ther 1989; 11: 604-613
9. Runyon BA, McHutchison JG, Antillon MR, Akriviadis EA, Montano AA. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 1991; 100: 1737-1742
10. Holland DJ, Sorrell TC. Antimicrobial therapy and prevention of spontaneous bacterial peritonitis. J Gastroenterol Hepatol 1993; 8: 370-374
11. Bhuva M, Ganger D, Jensen D. Spontaneous bacterial peritonitis: an update on evaluation, management, and prevention. Am J Med 1994; 97: 169-175
12. Garcia-Tsao G. Spontaneous bacterial peritonitis. Gastroenterol Clin North Am 1992; 21: 257-275
13. Felisart J, Rimola A, Arroyo V, Perez-Ayuso RM, Quintero E, Gines P, Rodes J. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 1985; 5: 457-462
14. Kaye D, Levison ME, Labovitz ED. The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function. J Infect Dis 1974; 130: 150-154
15. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987; 155: 93-99
16. Moreau L, Durand H, Biclet P. Cefotaxime concentrations in ascites. J Antimicrob Chemother 1980; 6 Suppl A: 121-122
17. Wade JC, Schimpff SC, Wiernik PH. Antibiotic combination-associated nephrotoxicity in granulocytopenic patients with cancer. Arch Intern Med 1981; 141: 1789-1793
18. Wade JC, Smith CR, Petty BG, Lipsky JJ, Conrad G, Ellner J, Lietman PS. Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside. Lancet 1978; 2: 604-606
19. Appel GB, Neu HC. The nephrotoxicity of antimicrobial agents (second of three parts). N Engl J Med 1977; 296: 722-728
20. Kahlmeter G, Dahlager JI. Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982. J Antimicrob Chemother 1984; 13 Suppl A: suppl A 9-22
21. Graudal N, Hubeck B, Bonde J, Thomsen AC. The prognostic significance of bacteremia in hepatic cirrhosis. Liver 1987; 7: 138-141